Related Experiment Video
Updated: Jun 3, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma
Marian Novak1, Stuart G Jarrett, Joseph R McCorkle
1Department of Molecular and Biomedical Pharmacology, College of Medicine, University of Kentucky, Lexington, KY 40536-0298, USA.
Abstract:
nm23-h1 was the first metastasis suppressor gene to be identified in humans, with early studies demonstrating its ability to inhibit the metastatic potential of breast carcinoma and melanoma cell lines. This report outlines recent findings from our laboratory indicating that the metastasis suppressor function of NM23-H1 in human melanoma involves a spectrum of molecular mechanisms. Analysis of NM23-H1-dependent profiles of gene expression in human melanoma cell lines has identified a host of target genes that appear to mediate suppression of directional motility. Of particular interest is a subset of motility-suppressing genes whose regulation by NM23-H1 is independent of its known kinase and 3'-5' exonuclease activities. In parallel, we have recently observed that NM23-H1 expression appears to be required for genomic stability and for optimal repair of DNA damage produced by ultraviolet radiation and other agents. Thus, NM23-H1 might oppose not only the motile and invasive characteristics of metastatic cells but also the acquisition of mutations that drive malignant progression to the metastatic phenotype itself.
Insights
The NM23-H1 gene suppresses melanoma metastasis through multiple mechanisms, including inhibiting cell movement and maintaining DNA stability. This discovery offers new insights into preventing cancer spread and progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- NM23-H1 is the first identified human metastasis suppressor gene.
- Early studies showed NM23-H1 inhibits metastasis in breast carcinoma and melanoma cell lines.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying NM23-H1's metastasis suppressor function in human melanoma.
- To investigate NM23-H1's role in regulating gene expression, cell motility, genomic stability, and DNA repair.
Main Methods:
- Gene expression profiling of human melanoma cell lines with varying NM23-H1 levels.
- Analysis of NM23-H1's regulation of target genes involved in cell motility.
- Assessment of NM23-H1's impact on genomic stability and DNA repair following UV radiation exposure.
Main Results:
- NM23-H1 regulates a set of genes that suppress directional cell motility.
- Some motility-suppressing genes are regulated by NM23-H1 independently of its kinase and exonuclease activities.
- NM23-H1 expression is crucial for maintaining genomic stability and efficient DNA damage repair.
Conclusions:
- NM23-H1 functions as a metastasis suppressor in melanoma through diverse molecular pathways.
- NM23-H1 inhibits both the invasive properties of metastatic cells and the accumulation of mutations driving malignancy.
- NM23-H1's multifaceted role suggests its potential as a therapeutic target for preventing cancer metastasis.
Related Concept Videos
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

